Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2023 | 1 |
2024 | 2 |
Search Results
2 results
Results by year
Filters applied: . Clear all
Page 1
Treatment patterns and clinical outcomes of chidamide combined with endocrine therapy in hormone receptor-positive, HER2-negative metastatic breast cancer: A real-world multicenter study.
Cancer Med. 2024 Feb;13(4):e6762. doi: 10.1002/cam4.6762.
Cancer Med. 2024.
PMID: 38457252
Free PMC article.
HER2-low heterogeneity between primary and paired recurrent/metastatic breast cancer: Implications in treatment and prognosis.
Lin M, Luo T, Jin Y, Zhong X, Zheng D, Zeng C, Guo Q, Wu J, Shao ZM, Hu X, Yang W, Zhang J.
Lin M, et al.
Cancer. 2024 Mar 15;130(6):851-862. doi: 10.1002/cncr.35101. Epub 2023 Nov 7.
Cancer. 2024.
PMID: 37933913
Item in Clipboard
Cite
Cite